A review of the biological role of miRNAs in prostate cancer suppression and progression
Prostate cancer (PC) is the third-leading cause of cancer-related deaths worldwide.
Although the current treatment strategies are progressing rapidly, PC is still representing a …
Although the current treatment strategies are progressing rapidly, PC is still representing a …
The promising role of new molecular biomarkers in prostate cancer: From coding and non-coding genes to artificial intelligence approaches
AP Alarcón-Zendejas, A Scavuzzo… - Prostate cancer and …, 2022 - nature.com
Background Risk stratification or progression in prostate cancer is performed with the
support of clinical-pathological data such as the sum of the Gleason score and serum levels …
support of clinical-pathological data such as the sum of the Gleason score and serum levels …
Updated review of advances in microRNAs and complex diseases: experimental results, databases, webservers and data fusion
MicroRNAs (miRNAs) are gene regulators involved in the pathogenesis of complex
diseases such as cancers, and thus serve as potential diagnostic markers and therapeutic …
diseases such as cancers, and thus serve as potential diagnostic markers and therapeutic …
Current achievements and applications of transcriptomics in personalized cancer medicine
S Supplitt, P Karpinski, M Sasiadek… - International Journal of …, 2021 - mdpi.com
Over the last decades, transcriptome profiling emerged as one of the most powerful
approaches in oncology, providing prognostic and predictive utility for cancer management …
approaches in oncology, providing prognostic and predictive utility for cancer management …
Landscape of noncoding RNA in prostate cancer
The transcriptome of prostate cancer is highly heterogeneous, with noncoding transcripts
being essential players. Long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) are …
being essential players. Long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) are …
Current advances of liquid biopsies in prostate cancer: Molecular biomarkers
Prostate cancer (PCa) incidence is increasing and endangers men's lives. Early detection of
PCa could improve overall survival (OS) by preventing metastasis. The prostate-specific …
PCa could improve overall survival (OS) by preventing metastasis. The prostate-specific …
[HTML][HTML] MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer
F Ghamlouche, A Yehya, Y Zeid, H Fakhereddine… - Translational …, 2023 - Elsevier
Prostate cancer (PCa) is one of the most commonly diagnosed cancers among men
worldwide. Despite the presence of accumulated clinical strategies for PCa management …
worldwide. Despite the presence of accumulated clinical strategies for PCa management …
[HTML][HTML] Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics
Prostate cancer is one of the most frequently diagnosed malignancies in developed
countries and approximately 248,530 new cases of prostate cancer are likely to be …
countries and approximately 248,530 new cases of prostate cancer are likely to be …
MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models …
Abstract Background Type 2 diabetes (T2D) is associated with coronary microvascular
dysfunction, which is thought to contribute to compromised diastolic function, ultimately …
dysfunction, which is thought to contribute to compromised diastolic function, ultimately …
Recent advances in duplex-specific nuclease-based signal amplification strategies for microRNA detection
Y Wu, S Cui, Q Li, R Zhang, Z Song, Y Gao… - Biosensors and …, 2020 - Elsevier
In recent years, miRNAs had emerged as promising biomarkers for diagnosis and prognosis
of the health-threatening diseases (eg, cancers), which associated with a broad range of …
of the health-threatening diseases (eg, cancers), which associated with a broad range of …